Patent Assignment
Reel/Frame 066987/0120
Partial Termination and Release of Security Interest in Patents
Recorded: 2024-04-03
Pages: 4
Assignor
JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Executed: 2024-03-28
Assignee
SLAYBACK PHARMA LIMITED LIABILITY COMPANY
301 CARNEGIE CENTER, SUITE 303, PRINCETON, NEW JERSEY, 08540
Covered Properties
(2)
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Pharmaceutical Compositions of Tofacitinib for Oral Administration
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 16, 2022
From: DUBE, SUSHANT OMPRAKASH; KULKARNI, PURUSHOTTAM DATTATRAYA; PATTEWAR, PURUSHOTTAM SAKHAHARI; PILLAI, SUMITRA ASHOKKUMAR
To: SLAYBACK PHARMA LLC
Reel/Frame 059025/0876 →
Security Interest
Sep 27, 2023
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 065045/0560 →
Assignment of Assignor's Interest
Apr 19, 2024
From: SLAYBACK PHARMA LIMITED LIABILITY COMPANY
To: HIKMA PHARMACEUTICALS USA INC.
Reel/Frame 067168/0238 →
Release of Security Interest
Mar 14, 2025
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: AZURITY PHARMACEUTICALS, INC.; SILVERGATE PHARMACEUTICALS, INC.; ARBOR PHARMACEUTICALS, LLC; SLAYBACK PHARMA LIMITED LIABILITY COMPANY
Reel/Frame 070521/0299 →